Trak Male Fertility Testing System
At-home male fertility testing system for sperm concentration measurement
Company profile
Company profile
Sandstone Diagnostics is a medical device company focused on developing innovative diagnostic solutions for reproductive health. The company specializes in creating accessible, user-friendly testing platforms that enable individuals and healthcare providers to assess fertility and reproductive health parameters outside of traditional clinical settings. Their technology aims to democratize access to reproductive health diagnostics by providing laboratory-quality results in convenient, at-home formats. Sandstone Diagnostics combines advanced microfluidics, imaging technology, and data analytics to deliver accurate, clinically validated diagnostic tools. The company's approach addresses the growing need for convenient, private, and cost-effective fertility testing solutions, particularly for male fertility assessment which has historically required clinical visits and laboratory analysis. By enabling at-home testing with smartphone-based analysis, Sandstone Diagnostics empowers individuals to take proactive steps in understanding and managing their reproductive health.
Company description Sandstone Diagnostics official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Embedded deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
At-home male fertility testing system for sperm concentration measurement
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Fertility and sterility · Sep 1, 2021
Clinical Evaluation of the Torq Zero Delay Centrifuge System for Decentralized Blood Collection and Stabilization.Diagnostics (Basel, Switzerland) · Jun 2, 2021
Male cellular telephone exposure, fecundability, and semen quality: results from two preconception cohort studies.Human reproduction (Oxford, England) · Apr 20, 2021
At-home sperm testing for epidemiologic studies: Evaluation of the Trak male fertility testing system in an internet-based preconception cohort.Paediatric and perinatal epidemiology · Sep 1, 2020
Novel centrifugal technology for measuring sperm concentration in the home.Fertility and sterility · Feb 1, 2017
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Sandstone Diagnostics's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.